HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Success of oxandrelone in the treatment of decubitus ulcers.

Abstract
A case of pressure ulcer in a 25-year-old male patient with the neurodegenerative disorder giant axonal neuropathy (GAN) was safely and effectively treated with an eight-week regimen of oxandrolone and nutritional supplementation. An initial dose of 5 mg twice daily was begun for the first two weeks of therapy, followed by six weeks of treatment with 10 mg twice daily. This therapy was supported with protein supplementation and adequate caloric intake. The patient's liver function tests were monitored weekly and remained within the normal range. His pressure ulcer was completely resolved at the conclusion of the eight weeks of therapy.
AuthorsKatherine B Madden, Agyrios Stampas, Seth B Forman
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) Vol. 9 Issue 6 Pg. 711-2 (Jun 2010) ISSN: 1545-9616 [Print] United States
PMID20645538 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anabolic Agents
  • Oxandrolone
Topics
  • Adult
  • Anabolic Agents (therapeutic use)
  • Humans
  • Male
  • Oxandrolone (adverse effects, therapeutic use)
  • Pressure Ulcer (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: